News
Media
Multimedia Series
Conferences
Partners
CME/CE
Resources
Advisory Board
Subscribe

Spotlight -

This Year In Medicine 2025

Robert S. Rosenson, MD

Robert S. Rosenson, MD

Robert S. Rosenson, MD is a professor of cardiology at the Icahn School of Medicine at Mount Sinai.

Articles by Robert S. Rosenson, MD

Robert Rosenson, MD | Image Credit: Mount Sinai

Evinacumab May Lower Triglycerides in Severe Hypertriglyceridemia, With Robert Rosenson, MD

ByRobert S. Rosenson, MD

January 9th 2026

Rosenson explains the data gained from a terminated phase 2b trial, highlighting evinacumab’s potential as a triglyceride-lowering therapy.

Solbinsiran Significantly Reduces apoB in Mixed Dyslipidemia in Phase 2 Trial| Image Credit: Mount Sinai

Solbinsiran Significantly Reduces apoB in Mixed Dyslipidemia in Phase 2 Trial

ByRobert S. Rosenson, MD

March 31st 2025

At ACC.25, Robert S. Rosenson, MD, discusses the efficacy and safety of solbinsiran, an ANGPTL3 inhibitor, in a population with mixed dyslipidemia.

Latest Updated Articles

Trending on HCPLive

Ecnoglutide Delivers 35% Greater Weight Loss Than Semaglutide in Head-to-Head Trial

Tezepelumab Reduces Severe Asthma Exacerbations by 70% in Phase 4 PASSAGE

Q&A: How Does the Current HS Landscape Look? With Kiera Booth, MD

Sutezolid Shows Promise as Safer Oxazolidinone in Novel 4-Month TB Regimen

CagriSema Outperforms Semaglutide Alone Across Phase 3 REIMAGINE Trials